Helen Shuk-ying Chan

Suggest Changes
  • Citations Per Year
Learn More
AIMS Chemotherapy with aggressive focal ablative therapy is now the mainstay of retinoblastoma therapy. Our experience presents an evolution from conventional radiotherapy by treating posterior pole(More)
  • 1